Testing effectiveness (Phase 2)Ended earlyNCT02610543What this trial is testingUCB Proof of Concept Study in Patients With Primary Sjögren's SyndromeWho this might be right forPrimary Sjögren's Syndrome UCB Celltech 27
Testing effectiveness (Phase 2)Ended earlyNCT02843659What this trial is testingProof of Concept Study to Evaluate the Efficacy and Safety of BMS-931699 (Lulizumab) or BMS-986142 in Primary Sjögren's SyndromeWho this might be right forSjögren's Syndrome Bristol-Myers Squibb 45
Not applicableUnknownNCT06530940What this trial is testingDiagnostic Interest of the Buccal Schirmer Test in Xerostomia During Sjögren's Syndrome: XERODIAGWho this might be right forSjogren's SyndromeXerostomiaDiagnosis University Tunis El Manar 180
Post-approval studies (Phase 4)UnknownNCT00543166What this trial is testingSex Steroids in Sjögren's Syndrome: Effect of Substitution Treatment on FatigueWho this might be right forSjogren's Syndrome University of Helsinki 107
Not applicableStudy completedNCT01807689What this trial is testingSalivary Biomarkers for Sjögren's Syndrome DetectionWho this might be right forSjögren's Syndrome University of California, Los Angeles 420
Not applicableNot Yet RecruitingNCT05056012What this trial is testingPenn SICCA Follow-up StudyWho this might be right forDry EyeSjogren's Syndrome University of Pennsylvania 220
Early research (Phase 1)Study completedNCT04093531What this trial is testingPilot Trial of Ustekinumab for Primary Sjögren's SyndromeWho this might be right forPrimary Sjögren Syndrome University of Rochester 12
Not applicableLooking for participantsNCT03003572What this trial is testingAutoreactive Anti-Ro/SSA IgE To Determine Primary SjögRen's Syndrome's Disease ActivityWho this might be right forPrimary Sjögren's Syndrome Centre Hospitalier Universitaire de Saint Etienne 185
Testing effectiveness (Phase 2)Study completedNCT04129164What this trial is testingEvaluate the Efficacy and Safety of VIB4920 in Participants With Sjögren's SyndromeWho this might be right forSjögren's Syndrome Amgen 183
Not applicableStudy completedNCT06982482What this trial is testingArtificial Intelligence Based Models for Primary Sjögren's Syndrome DiagnosisWho this might be right forPrimary Sjögren's Syndrome (pSS) The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 27,432
Testing effectiveness (Phase 2)Ended earlyNCT06312020What this trial is testingInvestigate Efficacy and Safety of HZN-1116 in Participants With Sjogren's SyndromeWho this might be right forSjogren's Syndrome Amgen 209
Not applicableStudy completedNCT04224454What this trial is testingVaccine Coverage and Primary Sjögren'SyndromeWho this might be right forPrimary Sjögren Syndrome University Hospital, Montpellier 111
Not applicableEnded earlyNCT04313725What this trial is testingEvaluation of Tangible Boost for Patients With Stevens Johnson Syndrome, Sjogren's Syndrome, and Graft Vs Host DiseaseWho this might be right forStevens-Johnson SyndromeGraft Versus Host Disease in EyeSjogren's Syndrome+1 more Tangible Science 28
Not applicableStudy completedNCT05079581What this trial is testingPelvic Floor Exercises in Patients With Sjögren'sWho this might be right forSjögrenSjögren Syndrome Akdeniz University 46
Post-approval studies (Phase 4)Looking for participantsNCT07277257What this trial is testingEvaluating a New Therapy for Dry Eye in Patients With Sjögren's SyndromeWho this might be right forSjogren Syndrome With Keratoconjunctivitis Center For Sight 35
Early research (Phase 1)Ended earlyNCT04684654What this trial is testingBMS-986325 in Healthy Participants and Participants With Primary Sjögren's SyndromeWho this might be right forHealthy ParticipantsPrimary Sjögren's Syndrome Bristol-Myers Squibb 118
Testing effectiveness (Phase 2)Ended earlyNCT04035668What this trial is testingEvaluate the Safety and Efficacy of LOU064 in Patients With Moderate to Severe Sjögren's SyndromeWho this might be right forSjögren Syndrome Novartis Pharmaceuticals 73
Testing effectiveness (Phase 2)Study completedNCT02334306What this trial is testingA Phase 2a, Randomized, Placebo Controlled, Study to Evaluate the Safety and Efficacy of AMG 557/MEDI5872 in Primary Sjögren's SyndromeWho this might be right forPrimary Sjögren's Syndrome MedImmune LLC 32
Not applicableActive Not RecruitingNCT07804719What this trial is testingPossible Sarcopenia, Sarcopenia, and Functional Status in Patients With Primary Sjögren's SyndromeWho this might be right forPrimary Sjögren SyndromeSarcopenia Antalya Training and Research Hospital 120
Testing effectiveness (Phase 2)Study completedNCT05817669What this trial is testingThe Safety and Effectiveness of Efgartigimod in Patients With Primary Sjögren's Syndrome (pSS)Who this might be right forPrimary Sjögren's Syndrome argenx 34